journal
https://read.qxmd.com/read/36368815/sports-cardiology-athlete-risk-identification-assessment-and-risk-mitigation
#1
EDITORIAL
Matthew W Martinez
No abstract text is available yet for this article.
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368814/the-tactical-athlete-definitions-cardiovascular-assessment-and-management-and-fit-for-duty-standards
#2
REVIEW
Jennifer Xu, Mark C Haigney, Benjamin D Levine, Elizabeth H Dineen
Tactical athletes are individuals in the military, law enforcement, and other professions whose occupations have significant physical fitness requirements coupled with the potential for exposure to life-threatening situations. Such exposures can have varied hemodynamic effects on the cardiovascular system. It is crucial that their clinical evaluation is inclusive of specific occupational requirements. Safety protocols regarding medical clearance are relatively more stringent for this population than for competitive athletes due to the increased impact to the tactical athlete, their team, and the population they aim to serve and protect should they experience a cardiovascular event on the job...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368813/devices-and-athletics-decision-making-around-return-to-play
#3
REVIEW
Bradley Kay, Rachel Lampert
Until recently, implantable cardioverter defibrillators (ICDs) were considered a contraindication to competitive athletics. Recent prospective observational registry data in athletes with ICDs who participated in sports against the societal recommendations at the time have demonstrated the safety of sports participation. While athletes did receive both appropriate and inappropriate shocks, these were not more frequent during sports participation than other activity, and there were no sports-related deaths or need for external resuscitation in the 440 athlete cohort (median followup 44 months)...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368812/cardiopulmonary-exercise-testing-interpretation-in-athletes-what-the-cardiologist-should-know
#4
REVIEW
Mustafa Husaini, Michael S Emery
The noninvasive assessment of oxygen consumption, carbon dioxide production, and ventilation during a cardiopulmonary exercise test (CPET) provides insight into the cardiovascular, pulmonary, and metabolic system's ability to respond to exercise. Exercise physiology has been shown to be distinct for competitive athletes and highly active persons (CAHAPs), thus creating more nuanced interpretations of CPET parameters. CPET in CAHAP is an important test that can be used for both diagnosis (provoking symptoms during a truly maximal test) and performance...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368811/anomalous-coronary-arteries-a-state-of-the-art-approach
#5
REVIEW
Silvana Molossi, Tam Doan, Shagun Sachdeva
Congenital coronary anomalies are not an infrequent occurrence and their clinical presentation typically occurs during early years, though may be manifested only in adulthood. In the setting of anomalous aortic origin of a coronary artery, this is particularly concerning as it inflicts sudden loss of healthy young lives. Risk stratification remains a challenge and so does the best management decision-making in these patients, particularly if asymptomatic. Standardized approach to evaluation and management, with careful data collection and collaboration among centers, will likely impact future outcomes in this patient population, thus allowing for exercise participation and healthier lives...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368810/the-international-criteria-for-electrocardiogram-interpretation-in-athletes-common-pitfalls-and-future-directions
#6
REVIEW
Bradley J Petek, Jonathan A Drezner, Timothy W Churchill
Preparticipation cardiovascular screening (PPCS) in young athletes is performed to detect conditions associated with sudden cardiac death. Many medical societies and sports governing bodies support the addition of a 12-lead electrocardiogram (ECG) to the history and physical to improve PPCS sensitivity. The current standard for ECG interpretation in athletes, the International Criteria, was developed to distinguish physiologic from pathologic ECG findings in athletes. Although application of the International Criteria has reduced the PPCS false-positive rate, interpretative challenges and potential areas of improvement remain...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368809/the-acute-impact-of-endurance-exercise-on-right-ventricular-structure-and-function-a-systematic-review-and-meta-analysis
#7
REVIEW
Tristan Ramcharan, Jamie Edwards, Jamie O'Driscoll, Michael Papadakis
There have been many studies since the late 1980s investigating the effect of endurance exercise on the left ventricle. More recently, attention has shifted to the right heart, with suggestions that endurance exercise may have a detrimental effect on the right ventricle. This systematic review and meta-analysis summarizes and critiques 26 studies, including 649 athletes, examining the acute impact of endurance exercise on the right ventricle. We also present a subanalysis contrasting ultraendurance with endurance exercise...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368808/hypertension-in-athletes-clinical-implications-and-management-strategies
#8
REVIEW
Jason V Tso, Jonathan H Kim
Hypertension is a leading cardiovascular risk factor in athletes. Sport-specific behaviors including nonsteroidal anti-inflammatory use, stimulant use, and unhealthy diets may promote hypertension among athletes. Strength-trained athletes may be more susceptible to hypertension than endurance-trained athletes, although this may, in part, be due to body size differences and the more potent antihypertensive effects of aerobic exercise. With confirmed hypertension, young athletes require secondary hypertension evaluation while older athletes require full cardiovascular risk stratification...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368807/exercise-after-acute-myocarditis-when-and-how-to-return-to-sports
#9
REVIEW
Robyn E Bryde, Leslie T Cooper, DeLisa Fairweather, Damian N Di Florio, Matthew W Martinez
Myocarditis is an inflammatory disease of the myocardium secondary to infectious and noninfectious insults. The most feared consequence of myocarditis is sudden cardiac death owing to electrical instability and arrhythmia. Typical presenting symptoms include chest pain, dyspnea, palpitations and/or heart failure. Diagnosis is usually made with history, electrocardiogram, biomarkers, echocardiogram, and cardiac MRI (CMR). Application of the Lake Louise criteria to CMR results can help identify cases of myocarditis...
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36368806/preparticipation-cardiac-evaluation-from-the-pediatric-perspective
#10
REVIEW
Andrew M Reittinger, Lanier B Jackson, Peter N Dean
Each year millions of children and adolescents undergo sports preparticipation evaluations (PPEs) before participating in organized sports. A primary aim of the PPE is to screen for risk factors associated with sudden cardiac death. This article is designed to summarize the current thoughts on the PPE with a specific slant toward the pediatric and early adolescent evaluation and how these evaluations may differ from those in adults.
February 2023: Cardiology Clinics
https://read.qxmd.com/read/36210138/heart-failure-with-preserved-ejection-fraction-the-future-is-now
#11
EDITORIAL
Matthew C Konerman, Scott L Hummel
No abstract text is available yet for this article.
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210137/transthyretin-cardiac-amyloidosis-an-evolution-in-diagnosis-and-management-of-an-old-disease
#12
REVIEW
Dia A Smiley, Carlos M Rodriguez, Mathew S Maurer
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome, and cardiac amyloidosis (CA) is one of the causes of HFpEF, that has established and emerging treatment options. However, it remains an underdiagnosed and often overlooked cause of HFpEF. The importance of early diagnosis cannot be emphasized enough, as emerging therapies are more effective early in the course of the disease. Further, because of the unique physiologic and hemodynamic features of CA, patients poorly tolerate traditional heart failure medications and experience worse outcomes compared with other causes of HFpEF...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210136/pulmonary-hypertension-in-heart-failure-with-preserved-ejection-fraction
#13
REVIEW
Victor M Moles, Gillian Grafton
Heart failure with preserved ejection fraction (HFpEF) is a common medical condition associated with increased morbidity and mortality. Through different mechanisms, including passive left-sided congestion and/or vasculopathy, patients with HFpEF can develop pulmonary hypertension (PH). This association -PH-HFpEF- is linked with worsening symptomatology and long-term outcomes. Although pulmonary vasodilators have been effective in treating patients with a pulmonary vasculopathy, such as pulmonary arterial hypertension (PAH), these results have not been replicated in those with PH-HFpEF...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210135/geriatric-domains-in-patients-with-heart-failure-with-preserved-ejection-fraction
#14
REVIEW
Parag Goyal, Omar Zainul, Dylan Marshall, Dalane W Kitzman
Because heart failure with preserved ejection fraction (HFpEF) is closely linked to aging processes and disproportionately affects older adults, consideration of geriatric domains is paramount to ensure high-quality care to older adults with HFpEF. Multimorbidity, polypharmacy, cognitive impairment, depressive symptoms, frailty, falls, and social isolation each have important implications on quality of life and clinical events including hospitalization and mortality. There are multiple strategies to screen for these conditions...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210134/device-therapy-for-heart-failure-with-preserved-ejection-fraction
#15
REVIEW
Husam M Salah, Allison P Levin, Marat Fudim
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with few options for effective pharmacologic therapies. Numerous device-based approaches to HFpEF therapy have emerged, which aim to treat the clinical and pathophysiologic features common to the varied causes of this syndrome. This review summarizes the current landscape of device therapy in HFpEF with a focus on structural interventions, such as left-to-right atrial shunts; cardiac contractility modulation; autonomic modulation, such as baroreflex activation therapy and splanchnic nerve modulation; and respiratory modulation, such as phrenic nerve stimulation...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210133/nonpharmacological-strategies-in-heart-failure-with-preserved-ejection-fraction
#16
REVIEW
Natalie J Bohmke, Hayley E Billingsley, Danielle L Kirkman, Salvatore Carbone
Patients with heart failure with preserved ejection fraction (HFpEF) suffer from a high rate of cardiometabolic comorbidities with limited pharmaceutical therapies proven to improve clinical outcomes and cardiorespiratory fitness (CRF). Nonpharmacologic therapies, such as exercise training and dietary interventions, are promising strategies for this population. The aim of this narrative review is to present a summary of the literature published to date and future directions related to the efficacy of nonpharmacologic, lifestyle-related therapies in HFpEF, with a focus on exercise training and dietary interventions...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210132/pharmacologic-therapy-for-heart-failure-with-preserved-ejection-fraction
#17
REVIEW
Anthony E Peters, Adam D DeVore
The management of heart failure with preserved ejection fraction (HFpEF) is rapidly evolving. The pharmacologic treatment of patients with HFpEF includes symptom management with diuretics and optimization of comorbidities, including hypertension, obesity, diabetes mellitus, and atrial fibrillation. Specific therapies, including angiotensin II receptor blockers, mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors, and sodium-glucose cotransporter-2 inhibitors, are well tolerated and can reduce the risk of HF hospitalization, particularly in those on the lower end of the HFpEF left ventricular ejection fraction spectrum...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210131/hemodynamic-assessment-in-heart-failure-with-preserved-ejection-fraction
#18
REVIEW
Kazunori Omote, Steven Hsu, Barry A Borlaug
Heart failure (HF) with preserved ejection fraction (HFpEF) is characterized by an inability of the heart to perfuse the body without pathologic increases in filling pressure at rest or during exertion. Right heart catheterization provides direct assessment for HF, providing the most robust and direct method to evaluate the central hemodynamic abnormalities, and serves as the gold standard to confirm or refute the presence of HFpEF. This article reviews current understanding of the best practices in the performance and interpretation of hemodynamic assessment, relates important pathophysiologic concepts to clinical care, and discusses current and evidence-based applications of hemodynamics in HFpEF...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210130/the-role-of-multimodality-imaging-in-the-evaluation-of-heart-failure-with-preserved-ejection-fraction
#19
REVIEW
Mahesh K Vidula, Paco E Bravo, Julio A Chirinos
Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, affecting approximately half of all patients with HF. The diagnosis of HFpEF can be notoriously challenging in clinical practice, given the many overlapping etiologies of dyspnea or reduced exercise tolerance in patients at risk for HFpEF. Multimodality imaging has an important role in establishing the diagnosis of HFpEF and the presence of elevated left ventricular filling pressures, identifying specific etiologies of HFpEF that can benefit from approved therapies, and discerning distinct phenogroups or mechanistic abnormalities that may inform the development of novel therapeutics...
November 2022: Cardiology Clinics
https://read.qxmd.com/read/36210129/approach-to-echocardiography-in-heart-failure-with-preserved-ejection-fraction
#20
REVIEW
C Charles Jain, Yogesh N V Reddy
As echocardiography is universally performed in the evaluation of suspected heart failure with preserved ejection fraction (HFpEF), a number of structural and functional characteristics relevant to both the diagnosis and phenotyping of HFpEF can be elucidated. Exclusion of alternate causes of heart failure is a critical first step performed principally by echocardiography. Once HFpEF is confirmed, echocardiography may provide insight into pathophysiology and phenotyping by quantifying atrial mechanics, pericardial restraint, degree of pulmonary hypertension, and atrial valvular regurgitation...
November 2022: Cardiology Clinics
journal
journal
28500
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.